Prices are the maximum retail price (MRP) published by DGDA, shown per strip for tablets and capsules. Prices marked market price are from retail listings where DGDA has not published one.
IndicationsLedipasvir is an antiviral medicine used, in a fixed combination tablet with Sofosbuvir, to treat chronic (long-term) hepatitis C virus infection in adults and children, mainly genotypes 1, 4, 5 and 6, including people with compensated cirrhosis (scarring…
IndicationsSofosbuvir is used to treat long-term (chronic) hepatitis C virus infection in adults. It is always taken together with other hepatitis C medicines, such as Velpatasvir, Ledipasvir or Daclatasvir, and sometimes Ribavirin. The doctor chooses the combination and…
Registration details and prices come from the public register of the Directorate General of Drug Administration (DGDA). This page is for information and does not replace advice from your doctor or pharmacist.